High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies

References

• Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet 2016;387:999–1011.
   PubMed Web of Science ®Google Scholar
• Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000;96:950–5.
   PubMed Web of Science ®Google Scholar
• Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003;22:203–12.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Bmj 2007;335:974
   PubMed Web of Science ®Google Scholar
• Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009;40:1176–80.
   PubMed Web of Science ®Google Scholar
• Strand KM, Heimstad R, Iversen AC, Austgulen R, Lydersen S, Andersen GL, Irgens LM, Vik T. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study. Bmj 2013;347:f4089.
   PubMed Web of Science ®Google Scholar
• Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012;36:56–9.
   PubMed Web of Science ®Google Scholar
• Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med 2015;5:1–21.
   Web of Science ®Google Scholar
• Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta Anaesthesiol Belg 2014;65:137–49.
   PubMedGoogle Scholar
• Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447–51.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int 2014;2014:297397.
   PubMedGoogle Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004;104:1367–91.
   PubMed Web of Science ®Google Scholar
• Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD. Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study. J Perinatol 2015;35:328–31.
   PubMed Web of Science ®Google Scholar
• Xu TT, Zhou F, Deng CY, Huang GQ, Li JK, Wang XD. Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis. J Clin Hypertens (Greenwich) 2015;17:567–73.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993;329:1213–18.
   PubMed Web of Science ®Google Scholar
• Ahrens KA, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Wactawski-Wende J, Galai N, Townsend JM, Lynch AM, Lesher LL, Faraggi D, Zarek S, Schisterman EF. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol 2016;127:689–98.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002;62:141–7.
   PubMed Web of Science ®Google Scholar
• Franceschini N, Qiu C, Barrow DA, Williams MA. Cystatin C and preeclampsia: a case control study. Ren Fail 2008;30:89–95.
   PubMed Web of Science ®Google Scholar
• Novakov Mikic A, Cabarkapa V, Nikolic A, Maric D, Brkic S, Mitic G, Ristic M, Stosic Z. Cystatin C in pre-eclampsia. J Matern Fetal Neonat Med 2012;25:961–5.
   PubMed Web of Science ®Google Scholar
• Thilaganathan B, Ralph E, Papageorghiou AT, Melchiorre K, Sheldon J. Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia. Reprod Sci 2009;16:788–93.
   PubMed Web of Science ®Google Scholar
• Kolialexi A, Gourgiotis D, Daskalakis G, Marmarinos A, Lykoudi A, Mavreli D, Mavrou A, Papantoniou N. Validation of serum biomarkers derived from proteomic analysis for the early screening of preeclampsia. Dis Markers 2015;2015:121848.
   PubMed Web of Science ®Google Scholar
• Thilaganathan B, Wormald B, Zanardini C, Sheldon J, Ralph E, Papageorghiou AT. Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia. Obstet Gynecol 2010;115:1233–8.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Lindstrom V, Schmidt C, Blirup-Jensen S, Grubb A, Wide-Swensson D, Strevens H. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest 2007;67:612–18.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, Lindstrom V, Strevens H, Grubb A. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand 2007;86:921–6.
   PubMed Web of Science ®Google Scholar
• Grubb A, Lindstrom V, Jonsson M, Back SE, Ahlund T, Rippe B, Christensson A. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'shrunken pore syndrome'. Scand J Clin Lab Invest 2015;75:333–40.
   PubMed Web of Science ®Google Scholar
• Grubb A, Abnormal glomerular filtration quality: a new marker for kidney disease. Use of cystatin C to identify it. In: Edelstein CL, ed. Biomarkers of kidney disease. 1st ed. London: Academic Press; 2011:302–4.
   Google Scholar
• Grubb A, Cystatin C as a multifaceted biomarker in kidney disease and its role in defining "Shrunken pore syndrome". In: Edelstein CL, ed. Biomarkers of Kidney Disease. 2nd ed. London: Elsevier; 2017:225–40.
   Google Scholar
• Purde MT, Nock S, Risch L, Medina Escobar P, Grebhardt C, Nydegger UE, Stanga Z, Risch M. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res 2016;169:80–90 e1-2.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS. Investigators C-E Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20–9.
   PubMed Web of Science ®Google Scholar
• Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS. GFR estimation using beta-trace protein and beta2-microglobulin in CKD. Am J Kidney Dis 2016;67:40–8.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 2016;374:13–22.
   PubMed Web of Science ®Google Scholar
• Purde MT, Baumann M, Wiedemann U, Nydegger UE, Risch L, Surbek D, Risch M. Incidence of preeclampsia in pregnant Swiss women. Swiss Med Wkly 2015;145:w14175.
   PubMed Web of Science ®Google Scholar
• International Federation of Clinical C, Laboratory M, Working Group on Standardization of Glomerular Filtration Rate A, Panteghini M, Myers GL, Miller WG, Greenberg N. The importance of metrological traceability on the validity of creatinine measurement as an index of renal function. Clin Chem Lab Med 2006;44:1287–92.
   PubMed Web of Science ®Google Scholar
• Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I, IWGoSoC C. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010;48:1619–21.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, Van Deventer M, Wang HY, Zuo L, Zhang YL, Levey AS. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 2011;79:555–62.
   PubMed Web of Science ®Google Scholar
• Grubb A, Horio M, Hansson LO, Bjork J, Nyman U, Flodin M, Larsson A, Bokenkamp A, Yasuda Y, Blufpand H, Lindstrom V, Zegers I, Althaus H, Blirup-Jensen S, Itoh Y, Sjostrom P, Nordin G, Christensson A, Klima H, Sunde K, Hjort-Christensen P, Armbruster D, Ferrero C. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem 2014;60:974–86.
   PubMed Web of Science ®Google Scholar
• Nyman U, Bjork J, Lindstrom V, Grubb A. The Lund-Malmö creatinine-based glomerular filtration rate prediction equation for adults also performs well in children. Scand J Clin Lab Invest 2008;68:568–76.
   PubMed Web of Science ®Google Scholar
• Pottel H, Hoste L, Dubourg L, Ebert N, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Mariat C, Martens F, Delanaye P. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 2016;31:798–806.
   PubMed Web of Science ®Google Scholar
• Pottel H, Delanaye P, Schaeffner E, Dubourg L, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Ebert N. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant 2017;32:497–507.
   PubMed Web of Science ®Google Scholar
• Leion F, Hegbrant J, den Bakker E, Jonsson M, Abrahamson M, Nyman U, Bjork J, Lindstrom V, Larsson A, Bokenkamp A, Grubb A. Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome. Scand J Clin Lab Invest 2017;77:338–44.
   PubMed Web of Science ®Google Scholar
• CLSI. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline. CLSI document EP28-A3c. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
   Google Scholar
• Risch L, Lhotta K, Meier D, Medina-Escobar P, Nydegger UE, Risch M. The serum uromodulin level is associated with kidney function. Clin Chem Lab Med 2014;52:1755–61.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest 2001;61:575–80.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, Larsen S, Nyengaard JR, Torffvit O, Willner J, Olsen S. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. Bjog 2003;110:825–30.
   PubMed Web of Science ®Google Scholar
• Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, Willner J, Olsen S. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Bjog 2003;110:831–6.
   PubMed Web of Science ®Google Scholar
• Stanga Z, Nock S, Medina-Escobar P, Nydegger UE, Risch M, Risch L. Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level. PloS One 2013;8:e72073.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652–60.
   PubMed Web of Science ®Google Scholar
• Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS. Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD. Am J Kidney Dis 2016;68:892–900.
   PubMed Web of Science ®Google Scholar
• Oberbauer R, Nenov V, Weidekamm C, Haas M, Szekeres T, Mayer G. Reduction in mean glomerular pore size coincides with the development of large shunt pores in patients with diabetic nephropathy. Nephron Exp Nephrol 2001;9:49–53.
   Google Scholar
• Rippe C, Rippe A, Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in early experimental diabetes in rats. Am J Physiol Ren Physiol 2007;293:F1533–8.
   PubMed Web of Science ®Google Scholar
• Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000;35:63–99.
   PubMed Web of Science ®Google Scholar
• Harrington MG, Aebersold R, Martin BM, Merril CR, Hood L. Identification of a brain-specific human cerebrospinal fluid glycoprotein, beta-trace protein. Appl Theor Electrophor 1993;3:229–34.
   PubMedGoogle Scholar
• Laurenzi MA, Link H. Characterisation of the mobility on isoelectric focusing of individual proteins in CSF and serum by immunofixation. J Neurol Neurosurg Psychiatr 1979;42:368–72.
   PubMed Web of Science ®Google Scholar
• Rindler MJ, Naik SS, Li N, Hoops TC, Peraldi MN. Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositol-linked membrane protein. J Biol Chem 1990;265:20784–9.
   PubMed Web of Science ®Google Scholar
• Scherberich JE, Gruber R, Nockher WA, Christensen IE, Schmitte H, Herbst V, Block M, Kadeng J, Schlumberger W. Serum Uromodulin: a biomarker of kidney function and renal parenchymal integrity. Nephrol Dial Transplant 2017. doi: 10.1093/ndt/gfw422.
   PubMed Web of Science ®Google Scholar
• Bleyer AJ, Kmoch S. Tamm horsfall glycoprotein and uromodulin: it is all about the tubules!. Clin J Am Soc Nephrol 2016;11:6–8.
   PubMed Web of Science ®Google Scholar
• Bellomo G. Serum uric acid and pre-eclampsia: an update. Expert Rev Cardiovasc Ther 2012;10:701–5.
   PubMedGoogle Scholar
• Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol 2005;25:56–60.
   PubMed Web of Science ®Google Scholar
• Boyle JA, Campbell S, Duncan AM, Greig WR, Buchanan WW. Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol 1966;19:501–3.
   PubMed Web of Science ®Google Scholar
• Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension 2011;58:704–8.
   PubMed Web of Science ®Google Scholar
• Laughon SK, Catov J, Powers RW, Roberts JM, Gandley RE. First trimester uric acid and adverse pregnancy outcomes. Am J Hypertens 2011;24:489–95.
   PubMed Web of Science ®Google Scholar
• Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, Lafond J, Legare F, Forest JC. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem 2010;56:361–75.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Strevens H, Lindstrom V, Grubb A, Wide-Swensson D. Increased plasma levels of beta2-microglobulin, cystatin C and beta-trace protein in term pregnancy are not due to utero-placental production. Scand J Clin Lab Invest 2008;68:649–53.
   PubMed Web of Science ®Google Scholar
• Mosimann B, Amylidi-Mohr S, Holand K, Surbek D, Risch L, Raio L. Importance of timing first-trimester placental growth factor and use of serial first-trimester placental growth factor measurements in screening for preeclampsia. Fetal Diagn Ther 2017;42:111–16.
   PubMed Web of Science ®Google Scholar